Atlas Trials

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients

Clinical trial NCT01223937 · COMPLETED

Trial details

NCT number
NCT01223937
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Nocturia
Start date
2010-11-01
Primary completion
2011-11-01
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.